TY  -  
T1  - Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis 
SN  -  /  
UR  - http://hdl.handle.net/10138/301993 
T3  -  
A1  - Makela, Mika J.; Gyllfors, Par; Valovirta, Erkka; Steffensen, Maria A.; Gronager, Pernille M.; Savolainen, Johannes; Winther, Lone 
A2  -  
PB  -  
Y1  - 2018 
LA  - eng 
AB  - Purpose: The SQ tree sublingual immunotherapy (SLIT)-tablet containing allergen extracts with the major allergen Bet v 1 from birch pollen is currently being developed for the treatment of tree pollen induced allergic rhinitis/conjunctivitis with or without asthma. The aim of this Phase II trial was to investigate the dose-related efficacy and safety of the SQ tree SLIT-tablet. Methods: This study was a randomized, parallel group, double-blind, placebo-controlled, multi-national trial conducted ... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - allergic rhinoconjunctivitis; birch pollen; clinical efficacy; immunology; sublingual immunotherapy tablet; tolerability; SUBLINGUAL IMMUNOTHERAPY; POLLEN ALLERGENS; RHINITIS; ASTHMA; BIRCH; TRIAL; PERSPECTIVE; DISEASE; UPDATE; IMPACT; 317 Pharmacy; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -